{"id":298269,"date":"2020-07-30T11:58:09","date_gmt":"2020-07-30T09:58:09","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=298269"},"modified":"2020-07-30T11:58:09","modified_gmt":"2020-07-30T09:58:09","slug":"argentina-pocela-ispitivanje-hiperimunog-konjskog-seruma","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2020\/07\/30\/argentina-pocela-ispitivanje-hiperimunog-konjskog-seruma\/","title":{"rendered":"Argentina po\u010dela ispitivanje hiperimunog konjskog seruma"},"content":{"rendered":"<p>Serum koji proizvodi biotehnolo\u0161ka kompanija Imunova, dobija se ubrizgavanjem proteina SARS-Cov-2 koji izaziva da \u017eivotinja stvara veliku koli\u010dinu neutrali\u0161u\u0107ih antitijela.<\/p>\n<p>Plazma se potom ekstrahuje iz konja, pro\u010di\u0161\u0107ava i obra\u0111uje.<\/p>\n<p>Posle pozitivnih rezultata laboratorijskih testova, u klini\u010dkim ispitivanjima efikasnosti seruma u\u010destvova\u0107e 242 osobe je su oboljele id COVID 19 u umjerenom do te\u0161kom obliku, prenosi Rojters.<\/p>\n<p>Prvi rezultati ispitivanja o\u010dekuju u oktobru ili novembru.<\/p>\n<p>U Argentini je potvr\u0111eno skoro 175.000 slu\u010dajeva korona virusa, a preminulo je oko 3.200 ljudi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Argentina je po\u010dela klini\u010dka ispitivanja za lije\u010denje COVID 19 koriste\u0107i hiperimuni serum razvijen pomo\u0107u antitijela iz konja, saop\u0161tila je laboratorija.<\/p>\n","protected":false},"author":1,"featured_media":296723,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-298269","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/298269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=298269"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/298269\/revisions"}],"predecessor-version":[{"id":298270,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/298269\/revisions\/298270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/296723"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=298269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=298269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=298269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}